Year: 2024

Objective response rate (ORR) of 46%, 12-month overall survival (OS) of 91.3% and a median overall survival (mOS) of 21.8 months in first line (1L) HPV+ R/M HNSCC patients treated with CUE-101 and KEYTRUDA® (pembrolizumab) ORR of 50% in 1L patients treated with CUE-101 and pembrolizumab with low PD-L1 expression (combined positive score (CPS) 1-19) 67% overall disease control rate (DCR) in late-stage pancreatic cancer patients treated with CUE-102 monotherapy, including an unconfirmed partial response (PR) with a 40% decrease in tumor burden CUE-101 data was presented in an oral session at SITC 2024 todayBOSTON, Nov. 08, 2024 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T...

Veteran initiatives core part of company values WEST JORDAN, Utah, Nov. 08, 2024 (GLOBE NEWSWIRE) — Sportsman’s Warehouse Holdings, Inc. (“Sportsman’s Warehouse” or the “Company”), https://www.sportsmans.com, an outdoor sporting goods specialty retailer, today announced the launch of an integrated program recognizing veterans and active-duty service members. The Honoring Your Service, Supporting Your Adventures program, demonstrates the retailer’s commitment to America’s military community. “We’d like to take a moment to recognize and honor all veterans,” states Paul Stone, Sportsman’s Warehouse CEO. “While we celebrate Veteran’s Day, our support for veterans isn’t a one-time initiative, but a core part of our company’s values and promise of providing great gear and great service...

Press Release Market update Bull SA issues preferred share to the French State to protect national interests in relation to sovereign sensitive activities carried out by Atos Paris, France – November 8, 2024 – Further to the agreement announced on June 26, 2024 between Atos SE (“Atos”), Bull SA and the French State, Atos announces that Bull SA has issued today a preferred share (action de préférence) for the benefit of the French State to protect national interests in respect of certain activities carried out by the Atos Group. The French State benefits from governance rights at the level of Bull SA, in particular rights of representation on corporate bodies (without voting rights at this stage) and prior authorization and approval rights (droits d’autorisation préalable et d’agrément) designed to protect sovereign sensitive activities....

Transparency notifications by Bank of America Corp.In accordance with article 14, § 1 of the law of 2 May 2007 on the disclosure of major holdings, Umicore was recently notified by:Bank of America Corp. that it has crossed the regulatory threshold of 3% for equivalent financial instruments downwards on 4 November 2024 and the threshold of 3% for direct voting rights and equivalent financial instruments downwards on 5 November 2024. The total holding of direct voting rights and equivalent financial instruments of Bank of America now stands at 2.94%.Summary of the moves:Date on which the threshold was crossed Date of notification Direct voting rights after the transaction Equivalent financial instruments after the transaction Total4 November 2024 5 November 2024 0.35 % 2.73 % 3.08 %5 November 2024 6 November 2024 0.22 % 2.72...

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Paris, France (November 8, 2024 – 6:00 pm) – As of October 31, 2024, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.  October 31, 2024Shares outstanding 457,322,5071Number of real voting rights (excluding treasury shares) 456,762,601Theoretical number of voting rights (including treasury shares) 457,322,507It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained in...

RONKONKOMA, N.Y., Nov. 08, 2024 (GLOBE NEWSWIRE) — Pineapple Energy Inc. (Nasdaq: PEGY) (Pineapple Energy) (“Pineapple” or the “Company”), a leading provider of sustainable solar energy and backup power to households, businesses, municipalities, and for servicing existing systems, today announced that it is changing its corporate name to SUNation Energy, Inc. (“SUNation”). The effective date for the name change will be announced in the near term. The corporate name change and a proposal to approve the redomestication and change in the Company’s legal state of incorporation from Minnesota to Delaware were each overwhelmingly approved at a Special Meeting of Shareholders held on November 4, 2024.    “The adoption of SUNation Energy, Inc. as our corporate name leverages the significant brand equity we have built over the last 20-plus...

8 November 2024 New Release   BioPorto Sponsors Exhibits to Showcase Launch of ProNephro AKI in the U.S. and Ongoing Marketing of The NGAL Test to Clinicians at Major Healthcare Conferences   COPENHAGEN, DENMARK and BOSTON, MA, USA, November 8, 2024 – BioPorto Diagnostics, a pioneering company in the field of diagnostic biomarkers, today announced that the Company has sponsored exhibits at the following clinical healthcare conferences via invitation from conference organizers: 10th World Academic Congress of Emergency Medicine (WACEM 24), Rome, Italy (November 6th to 8th, 2024) 22nd Annual California Association of Neonatologists Annual Academic Day, Irvine, CA, (November 7, 2024) PICNIC: “Pediatric Intensive, Cardiac, and Neonatal Intensive Care Collaborative Conference”, New York, New York (November 8, 2024) Jennifer Zonderman...